Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK extends high-street eyecare scope - a diagnostic/surgical opportunity?:

This article was originally published in Clinica

Executive Summary

UK optometrists have welcomed the government's approval of plans to extend prescribing to high-street eyecare providers as promising a developing role in the specialism. "Allowing optometrists to prescribe independently will complement their existing diagnostic skills and further develop their role in the management of eye disease," said Kevin Lewis, president of the College of Optometrists. The new prescribing powers, which are backed by the General Optical Council, were the subject of a consultation that ended in October 2006. The College of Optometrists is heading the development of new clinical management guidelines for the specialism.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel